Obesity is a chronic metabolic and genetic disease which involves accumulation of unnecessary or unusual fat in the body. It is mainly caused by increased fatty intake, reduced physical exercises and genetic inheritance. According to the World Health Organization (WHO), person having body mass index (BMI) more than 30 is considered as an obese. Obesity surgeries, also known as bariatric surgery, decrease the size of stomach by implanting gastric band or intragastric balloon in it, in order to limit the amount of food human stomach can hold. It limits the quantity of food consumers can ingest, which leads to severe weight loss.
For more information visit: https://www.psmarketresearch.com/market-analysis/obesity-surgery-devices-market
Obesity surgeries has an advantageous effect on many medical conditions such as acid reflux, diabetes, low back pain, sleep apnea, acid reflux, polycystic ovary syndrome (PCOS), hypertension and urinary stress incontinence. Obesity surgeries result in 40% to 80% weight loss after two to three years, depending on the way obesity surgery had been proposed. Increasing prevalence of obesity among children and adults is creating a threat in developed and developing nations. Some of the surgical instruments used in obesity surgery are Aesculap, ConMed EndoSurgery, Wilson-Cook Medical, Karl Storz, and Silhouette Medical.
On the basis of procedure, global obesity surgery devices market can be categorized as biliopancreatic diversion with duodenal switch, adjustable gastric banding, Roux-en-Y gastric bypass and sleeve gastrectomy. Based on the various device types, the global obesity surgery devices market can be categorized as intragastric balloons, gastric electrical stimulators, gastric bands and staples.
Request for Table of Content: https://www.psmarketresearch.com/enquiry-form.php?enqid=130&title=TOC
North America dominates the global obesity surgery devices markets followed by Europe and Asia-Pacific. The dominance in North America region is attributed to high population of obese and rising public awareness towards the ill effect of obesity in the region; also, growing demand for less invasive procedures and obesity treatment in the region. According to the U.S. Centre for Disease Control and Prevention (CDC), 68% of the total adult population in the U.S. is obese.
Some of the major competitors in obesity surgery devices market are, Medtronic plc, Johnson & Johnson Services Inc, Covidien, Allergan Inc., W.L. Gore & Associates Inc, Olympus Corporation, USGI Medical Inc., Spatz FGIA Inc., IntraPace Inc., ReShape Medical Inc., Satiety Inc., Aspire Bariatrics LLC, and MetaCure Limited.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Deep
Assistant – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
US/ Canada Toll-Free: 1-888-778-7886
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com